This paper (Parts I and II) reviews the measures employed in studying
the brain neurophysiological activities of clinical pain. In Part II,
these measures include the imaging and measurement of brain blood flow
and hemodynamics in various regions of the brain, the scanning of gro
ss and fine brain structures by computerized axial tomography or magne
tic resonance imaging, and the imaging and measurement of brain metabo
lic changes, energy uptake, and receptors bindings through positron em
ission tomography or single-photon emission computerized tomography. M
olecular chemical transformation by the nuclear magnetic resonance ana
lysis of tissue changes and analgesic-receptor interactions is also no
ted. Most studies of the cerebral measures of traumatic and pathophysi
ological pain reported in the literature are concerned with headache.
The relationships of brain activities among sensory processes of nocic
eption, subjective experience of pain intensity and quality, emotional
reaction, and cognitive coping often are complex and not well elucida
ted in man. Although significant changes in the cerebral physiological
parameters are frequently reported in pain patients, the specificity
and sensitivity of these measures as objective markers for human pain,
reviewed from Part I and Part II together, has not yet been conclusiv
ely defined. Also, normative data basis and criteria for classifying a
bnormality of these brain measures must be established and their valid
ity and reliability be carefully examined so that they can be confiden
tly applied in diagnosis and management of clinical pain. Nevertheless
, advancement on measurement of temporal dynamics in 3-D topographic m
apping of cortical activities and source localization modeling, togeth
er with tomographic imaging of neurochemical metabolisms in the brain
will further our scientific understanding of cerebral pain mechanisms.
A window on the brain of human pain is being opened.